Company Outlines Strategy to Position OneTest™ as the First Affordable, Multi-Cancer Early Detection Blood Test for Earlier Stage ...

Expanding on IVBM insights, Robert Kratzke, MD, discusses biomarkers, NGS panels, and treatment options for early-stage NSCLC without actionable alterations.

Longevity medicine relies on advanced biomarker analysis to support preventive healthcare and more personalized patient ...

Robert Kratzke, MD, calls for a national biomarker testing mandate, emphasizing that timely genomic testing is essential for precision lung cancer care. In part 2 of an interview with The American ...

Learn why comprehensive biomarker testing is essential before starting any lung cancer treatment. Hear from patients and ...

BeiGene is back with a new partnership and oncology campaign to raise awareness about biomarker testing for patients with chronic lymphocytic leukemia (CLL), a blood cancer marked by the ...

Dr. John Marshall explains why biomarker testing should be done early in colorectal cancer to guide treatment and identify targeted therapies. Biomarker testing is no longer optional in colorectal ...

Although treatment of advanced gastroesophageal cancer is increasingly dependent on biomarkers, only about 40% of patients are tested. For patients to fully benefit from the latest targeted therapies, ...

Biomarker testing in colorectal cancer (CRC) informs doctors about unique features of cancer that may influence its growth, spread, recurrence, and treatment response. Colorectal cancer (CRC), which ...

For millions of people living with depression, finding an effective treatment can feel like a long and uncertain journey.

A painless brush swab may soon change one of the most unpleasant parts of oral cancer care, sorting dangerous mouth lesions ...